A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans

Name: A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
SKU: 4094
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 1 Articles Tags: ann-rasmusson, elizabeth-frazier-ms, guanfacine, jason-m-newell, l-charles-ward, lori-davis, md, noradrenergic, norepinephrine, pharmacologic-treatment, phd, posttraumatic-stress-disorder

Description

A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans

Description

Lori Davis, MD Link

ORIGINAL RESEARCH

A Placebo-Controlled Trial of Guanfacine for the Treatment of Post Traumatic Stress Disorder in Veterans

Lori Davis, MD, L. Charles Ward, PhD, Ann Rasmusson,MD, Jason M. Newell, PhD, Elizabeth Frazier MS, and Steven M. Southwick, MD

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans

Description

Lori Davis, MD Link

ORIGINAL RESEARCH

A Placebo-Controlled Trial of Guanfacine for the Treatment of Post Traumatic Stress Disorder in Veterans

Lori Davis, MD, L. Charles Ward, PhD, Ann Rasmusson,MD, Jason M. Newell, PhD, Elizabeth Frazier MS, and Steven M. Southwick, MD

Related products

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD